Dicerna Announces New Technology

PMDF_discerna_blog_2016x893.jpg

We are very excited to learn of Dicerna's new technology to deliver medicines to cell types in the brain including oligodendrocytes. 

Since PMD affects oligodendrocytes in the brain, we're eager to follow Dicerna's continued research in this area and hope it may facilitate new treatment options for PMD patients.

Learn more about this news.

Maureen Ballatori